<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although traditionally used for <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e>, there has been a recent interest in serum D-dimer as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this prospective study is to determine its value as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> marker in patients with colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Between January 2000 and October 2007, 242 patients undergoing laparoscopic radiofrequency ablation (RFA) of colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> were evaluated prospectively </plain></SENT>
<SENT sid="3" pm="."><plain>The relationship of D-dimer levels to pre-ablation parameters, recurrence, and survival was prospectively assessed </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> data are expressed as mean ± <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Preoperative D-dimer levels correlated with <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumor</z:e> volume (p = .04) and CEA (p = .003) </plain></SENT>
<SENT sid="6" pm="."><plain>D-dimer levels increased by a mean of 11.4 ± 1.5 folds after RFA on POD#7 and returned to preoperative values in three months </plain></SENT>
<SENT sid="7" pm="."><plain>The rate of the elevation of D-dimer values after RFA was related to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volume ablated </plain></SENT>
<SENT sid="8" pm="."><plain>The median overall survival was six months for patients with preoperative D-dimer &gt; 1,000 ng/ml vs. 32 months for patients with D-dimer &lt; 1,000 ng/ml (p = .02) </plain></SENT>
<SENT sid="9" pm="."><plain>On multivariate analysis preoperative serum D-dimer was an independent predictor of overall survival along with CEA and <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumor</z:e> burden </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Serum D-dimer levels reflect <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumor</z:e> burden and independently predict survival in patients with colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> undergoing RFA </plain></SENT>
</text></document>